摘要
目的 了解和掌握输血前患者血清标志物的感染状况。方法 采用酶联免疫吸附（ELISA）法对3480例输血前患者进行乙型肝炎病毒表面抗原（HBsAg）、丙型肝炎病毒抗体（抗-HCV）、梅毒抗体（抗-TP）、艾滋病病毒抗体（抗-HIV）检测；并对前3种标志物阳性患者不同性别、年龄作统计分析。结果 3480例患者中HBsAg、抗-HCV、抗-TP、抗-HIV的阳性率分别为11．10％、0．40％、4．30％、0．08％；对197例HBsAg、71例抗-TP和22例抗～HCV阳性患者按性别和年龄进行分组比较，除了HBsAg、抗-TP阳性患者性别差异无统计学意义（P〉0．05）外，其余差异均有统计学意义（P〈0．01）。结论 （1）HBsAg、抗-HCV、抗-TP阳性患者中40岁以上较高，表明中老年健康值得关注。（2）对受血者输血前血清标志物检测，有利于医患双方采取有效的预治措施，同时避免医疗纠纷的发生。
Objective To investigate the status of infected markers of patients before blood transfusion. Methods 3 480 cases of patients before transfusion were enrolled. HBsAg, anti-HCV, anti-TP and anti-HIV were detected by enzyme-linked immunosorbent assay （ELISA）. At the same time, the former three positive markers were analysed statistically in age and sex. Results The positive rate of HBsAg, anti-HCV, anti-TP and anti-HIV was 11.10%, 0. 400%, 4.30% and 0.08% respectively. 197 cases with positive HBsAg, 22 cases with positive HCV and 71 cases with positive TP were compared at age and sex. Only cases with positive HBsAg and TP were not significantly different in sex（P〉0.05）, the rest was much significantly different （P〈0.01） in both age and sex. Conclusion （1）The positive rates with HBsAg, anti-HCV and anti-TP was high in more than age 40 year-old, which should be paid more attention to. （2） Determination of serum markers of patients before blood transfusion is helpful for doctors and patients to prevent and cure the diseases. And it can avoid medical dispute.
出处
《国际检验医学杂志》
CAS
2007年第4期347-349,共3页
International Journal of Laboratory Medicine
关键词
输血
肝炎表面抗原
乙型
肝炎抗体
丙型
梅毒
HIV抗体
酶联免疫吸附测定
Before transfusion
Hepatitis B surface antigens
Hepatitis C antibodies
Syphilis
HIV antibodies
Enzyme-linked immunosorben
assay
